Home › Rheumatoid Arthritis › North Carolina › Charlotte
Rheumatoid Arthritis clinical trials in Charlotte, NC
4 studies for Rheumatoid Arthritis are looking for participants at sites in and around Charlotte (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
Recruiting
- Carolina Orthopaedic and Sports Medicine Center, Gastonia · 20 mi away
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
RecruitingPhase 2
- Joint And Muscle Research Institute /ID# 277290, Charlotte
- DJL Clinical Research - Charlotte /ID# 272387, Charlotte
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
RecruitingPhase 1/2
- Nkarta Investigational Site, Charlotte
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
RecruitingPhase 2
- Artiva Investigational Site Charlotte, Charlotte
- Artiva Investigational Site Charlotte, Charlotte
About Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a form of arthritis that causes pain, swelling, and stiffness in your joints. Your risk increases as you become an older adult.
More about Rheumatoid Arthritis on MedlinePlus
Rheumatoid Arthritis trials in other cities
- Houston, TX11 studies
- New York City, NY10 studies
- Durham, NC8 studies
- Dallas, TX7 studies
- Aurora, CO7 studies
- Altoona, PA7 studies
- Boston, MA7 studies
- Plantation, FL6 studies
- San Diego, CA6 studies
- Chicago, IL6 studies
- Miami, FL5 studies
- West Palm Beach, FL5 studies
Other studies in Charlotte
- Cancer (all types)27 studies
- Breast Cancer22 studies
- Multiple Myeloma21 studies
- Non-Small Cell Lung Cancer19 studies
- Acute Myeloid Leukemia16 studies
- Obesity16 studies
- Overweight15 studies
- Colorectal Cancer13 studies
- Ovarian Cancer12 studies
- Heart Failure11 studies
- Metastatic Cancer11 studies
- Head and Neck Squamous Cell Carcinoma10 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.